top of page

September 2022 // Company & Communication


Synendos Therapeutics is ranked TOP 100 Swiss Startups 2022


We are honored to be listed for the second year in a row as one of the TOP 100 Swiss Startups 2022. A big thank you to our team, partners, collaborators, and investors.

https://www.linkedin.com/feed/update/urn:li:activity:6973356870988128256


https://twitter.com/venturelab_ch/status/1567797207071334400

Recent Posts

See All

Synendos Therapeutics AG announces that co-founder and Scientific Advisor Board member, Professor Jürg Gertsch, presented groundbreaking new findings on an endocannabinoid transporter at the 10th Gord

Synendos Therapeutics has been awarded with the Innosuisse Certificate Synendos has been awarded the Innosuisse certificate by Innosuisse Innovation Council. The Innosuisse certificate reflects remark

bottom of page